Cargando…

Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments

SIMPLE SUMMARY: In order to clarify whether an early development of brain metastases from non-small cell lung cancer represents a poor prognostic factor for further survival we analyzed 377 patients with brain metastases, treated by radiosurgery or surgery at two German institutions. Our results sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jünger, Stephanie T., Schödel, Petra, Ruess, Daniel, Ruge, Maximilian, Brand, Julia-Sarita, Wittersheim, Maike, Eich, Marie-Lisa, Schmidt, Nils-Ole, Goldbrunner, Roland, Grau, Stefan, Proescholdt, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761690/ https://www.ncbi.nlm.nih.gov/pubmed/33287226 http://dx.doi.org/10.3390/cancers12123618

Ejemplares similares

Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment
por: Schödel, Petra, et al.
Publicado: (2020)

Brain Metastases in Elderly Patients—The Role of Surgery in the Context of Systemic Treatment
por: Proescholdt, Martin, et al.
Publicado: (2021)

The Debatable Benefit of Gross-Total Resection of Brain Metastases in a Comprehensive Treatment Setting
por: Jünger, Stephanie T., et al.
Publicado: (2021)

MLTI-03. The relevance of the count of brain metastases for treatment and outcome in NSCLC
por: Reinecke, David, et al.
Publicado: (2021)

MLTI-02. Impact of driver mutations on timing, pattern, treatment, and outcome in patients with brain metastases from non-small cell lung cancer
por: Jünger, Stephanie, et al.
Publicado: (2021)

Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer
por: Meißner, Anna-Katharina, et al.
Publicado: (2023)

Cyberknife(®) hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases
por: Telentschak, Sergej, et al.
Publicado: (2021)

ETMR-04. Embryonal tumor with multi-layered rosettes (ETMR) located in the brainstem: a case report on clinical decision-making and a multimodal, interdisciplinary treatment approach including interstitial brachytherapy
por: Jünger, Stephanie T, et al.
Publicado: (2022)

Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting
por: Heßler, Nadine, et al.
Publicado: (2022)

The Management of Brain Metastases—Systematic Review of Neurosurgical Aspects
por: Proescholdt, Martin A., et al.
Publicado: (2021)

Brain metastases from esophageal cancer: A retrospective analysis of the outcome after surgical resection followed by radiotherapy
por: Stavrinou, Pantelis, et al.
Publicado: (2019)

Surgical Resection of Brain Metastases—Impact on Neurological Outcome
por: Schödel, Petra, et al.
Publicado: (2013)

SURG-04. Surgical resection of symptomatic brain metastasis in patients with non-small cell lung cancer irrespective from lesion count
por: Jünger, Stephanie T, et al.
Publicado: (2021)

Deep convolutional neural networks for automated segmentation of brain metastases trained on clinical data
por: Bousabarah, Khaled, et al.
Publicado: (2020)

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
por: Trommer-Nestler, Maike, et al.
Publicado: (2018)

Case report: Use of (68)Ga-DOTATATE-PET for treatment guidance in complex meningioma disease
por: Meißner, Anna-Katharina, et al.
Publicado: (2022)

Radiotoxicity in robotic radiosurgery: proposing a new quality index for optimizing the treatment planning of brain metastases
por: Hellerbach, Alexandra, et al.
Publicado: (2017)

Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
por: Trommer, Maike, et al.
Publicado: (2022)

The endogenous neuropeptide calcitonin gene-related peptide after spontaneous subarachnoid hemorrhage–A potential psychoactive prognostic serum biomarker of pain-associated neuropsychological symptoms
por: Bründl, Elisabeth, et al.
Publicado: (2022)

Long-term follow-up after stereotactic radiosurgery of intracanalicular acoustic neurinoma
por: Rueß, Daniel, et al.
Publicado: (2017)

Stereotactic radiosurgery for treating meningiomas eligible for complete resection
por: Ruge, Maximilian I., et al.
Publicado: (2021)

Pseudoprogression of Vestibular Schwannoma after Stereotactic Radiosurgery with Cyberknife(®): Proposal for New Response Criteria
por: Rueß, Daniel, et al.
Publicado: (2023)

Ventriculostomy-related intracranial hemorrhage following surgical and endovascular treatment of ruptured aneurysms
por: Lenschow, Moritz, et al.
Publicado: (2022)

Novel rapid intraoperative qualitative tumor detection by a residual convolutional neural network using label-free stimulated Raman scattering microscopy
por: Reinecke, David, et al.
Publicado: (2022)

Stereotactic radiosurgery of benign brain tumors in elderly patients: evaluation of outcome and toxicity
por: Rueß, Daniel, et al.
Publicado: (2020)

Image-Guided Robotic Radiosurgery for the Management of Intramedullary Spinal Cord Metastases—A Multicenter Experience
por: Ehret, Felix, et al.
Publicado: (2021)

KRAS mutation in papillary fibroelastoma: a true cardiac neoplasm?
por: Wittersheim, Maike, et al.
Publicado: (2017)

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
por: Berghoff, Anna Sophie, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC
por: Gal, Omer, et al.
Publicado: (2020)

Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
por: Bründl, Elisabeth, et al.
Publicado: (2020)

Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system
por: Rueß, Daniel, et al.
Publicado: (2020)

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Facial nerve paralysis caused by a T‐cell lymphoma
por: Nachtsheim, Lisa, et al.
Publicado: (2020)

Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment
por: Chan, Kun-Ming, et al.
Publicado: (2011)

Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
por: Ono, Takashi, et al.
Publicado: (2022)

Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series
por: van Schie, P., et al.
Publicado: (2023)

32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
por: Galldiks, Norbert, et al.
Publicado: (2020)

Breakouts—A Radiological Sign of Poor Prognosis in Patients With Brain Metastases
por: Blazquez, Raquel, et al.
Publicado: (2022)

Meningioma infiltrating into porous polymethylmethacrylate cranioplasty—report of a unique case
por: Schebesch, Karl-Michael, et al.
Publicado: (2020)

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study
por: Daugherty, Emily C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2c1np7itb2uuutlvegj25b2hal